Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Tohoku J Exp Med ; 237(1): 57-67, 2015 09.
Article in English | MEDLINE | ID: mdl-26353909

ABSTRACT

Vascular dementia (VD) has been one of the most serious public health problems worldwide. It is well known that cerebral hypoperfusion is the key pathophysiological basis of VD, but it remains unclear how global genes in hippocampus respond to cerebral ischemia-reperfusion. In this study, we aimed to reveal the global gene expression profile in the hippocampus of VD using a rat model. VD was induced by repeated occlusion of common carotid arteries followed by reperfusion. The rats with VD were characterized by deficit of memory and cognitive function and by the histopathological changes in the hippocampus, such as a reduction in the number and the size of neurons accompanied by an increase in intercellular space. Microarray analysis of global genes displayed up-regulation of 7 probesets with genes with fold change more than 1.5 (P < 0.05) and down-regulation of 13 probesets with genes with fold change less than 0.667 (P < 0.05) in the hippocampus. Gene Ontology (GO) and pathway analysis showed that the up-regulated genes are mainly involved in oxygen binding and transport, autoimmune response and inflammation, and that the down-regulated genes are related to glucose metabolism, autoimmune response and inflammation, and other biological process, related to memory and cognitive function. Thus, the abnormally expressed genes are closely related to oxygen transport, glucose metabolism, and autoimmune response. The current findings display global gene expression profile of the hippocampus in a rat model of VD, providing new insights into the molecular pathogenesis of VD.


Subject(s)
Dementia, Vascular/genetics , Gene Expression/genetics , Hippocampus/metabolism , Animals , Autoimmune Diseases/immunology , Carotid Stenosis/complications , Carotid Stenosis/genetics , Carotid Stenosis/physiopathology , Dementia, Vascular/etiology , Dementia, Vascular/metabolism , Encephalitis/etiology , Encephalitis/pathology , Glucose/metabolism , Male , Maze Learning , Memory Disorders/etiology , Memory Disorders/genetics , Memory Disorders/psychology , Microarray Analysis , Oxygen Consumption , Rats , Rats, Sprague-Dawley , Reperfusion Injury/complications , Reperfusion Injury/genetics , Reperfusion Injury/physiopathology , Up-Regulation
2.
Mol Med Rep ; 12(3): 4273-4283, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26094797

ABSTRACT

Apoptosis and the dysfunction of the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/cAMP-responsive element binding protein (CREB) signaling pathway have a key role in memory impairment in vascular dementia (VaD), a challenging clinical problem. Yifei Xuanfei Jiangzhuo formula (YXJF), a Chinese herbal decoction, has been used to treat VaD in clinical practice and has produced positive outcomes; however, convincing evidence is currently lacking. The present study aimed to investigate the effects of YXJF on memory impairment in rats with cerebral ischemia/reperfusion and to explore the underlying mechanism. YXJF ameliorated memory impairment in rats with cerebral ischemia/reperfusion, inhibited hippocampal apoptosis in a dose-dependent manner and attenuated increases in the protein expression of B-cell lymphoma 2 (Bcl-2)-associated X protein as well as c-Jun and a reduction in Bcl-2 protein expression in the hippocampal tissue of the rats. Furthermore, administration of YXJF significantly increased the protein expression of PKA C-α and CREB, and promoted CREB phosphorylation. The results indicated that YXJF improves memory impairment through inhibiting apoptosis and enhancing PKA/CREB signal transduction in rats with cerebral ischemia/reperfusion.


Subject(s)
Brain Ischemia/drug therapy , Drugs, Chinese Herbal/pharmacology , Memory Disorders/drug therapy , Neuroprotective Agents/pharmacology , Reperfusion Injury/drug therapy , Animals , Apoptosis , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Brain Ischemia/complications , Brain Ischemia/psychology , CA1 Region, Hippocampal/drug effects , CA1 Region, Hippocampal/pathology , Cyclic AMP Response Element-Binding Protein/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Drug Evaluation, Preclinical , Male , Maze Learning , Memory Disorders/etiology , Neuroprotective Agents/therapeutic use , Phosphorylation , Protein Processing, Post-Translational , Rats, Sprague-Dawley , Reperfusion Injury/complications , Reperfusion Injury/psychology , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...